US 12,303,668 B2
Adjusting insulin delivery rates
Bryan Mazlish, Palo Alto, CA (US); and Lane Desborough, Thousand Oaks, CA (US)
Assigned to Insulet Corporation, Acton, MA (US)
Filed by Insulet Corporation, Acton, MA (US)
Filed on Oct. 15, 2021, as Appl. No. 17/451,128.
Application 17/451,128 is a continuation of application No. 16/393,831, filed on Apr. 24, 2019, granted, now 11,147,921.
Application 16/393,831 is a continuation of application No. 15/406,313, filed on Jan. 13, 2017, granted, now 10,307,538, issued on Jun. 4, 2019.
Claims priority of provisional application 62/340,470, filed on May 23, 2016.
Claims priority of provisional application 62/278,978, filed on Jan. 14, 2016.
Prior Publication US 2022/0031949 A1, Feb. 3, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/172 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/145 (2006.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 10/60 (2018.01); G16H 40/40 (2018.01); G16H 50/30 (2018.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 5/142 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/145 (2013.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); A61B 2562/0295 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/005 (2013.01); A61M 2230/201 (2013.01); G16H 10/60 (2018.01); G16H 40/40 (2018.01); G16H 50/30 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A method of providing insulin delivery instructions for an insulin delivery device, the method comprising:
selecting a first user-specific basal delivery profile permutation from a plurality of user-specific basal delivery profile permutations, the first user-specific basal delivery profile permutation having an intended basal rate and an intended delivery time duration for the intended basal rate;
generating insulin delivery instructions comprising the intended basal rate of the first user-specific basal delivery profile permutation and a first variable delivery time duration relative to the intended delivery time duration of the first user-specific basal delivery profile permutation; and
providing the generated insulin delivery instructions to the insulin delivery device.